Literature DB >> 2996210

Vaccines against Aujeszky's disease: evaluation of their efficacy under standardized laboratory conditions.

P W de Leeuw, J T van Oirschot.   

Abstract

A standardized test was developed to compare the efficacy of Aujeszky's disease virus (ADV) vaccines under laboratory conditions. Per test 3 groups of 6 to 8 sero-negative pigs were used. The first vaccination was done at 10 weeks of age. One group was vaccinated once, another was vaccinated twice and the 3rd served as control. Pigs were challenge exposed to the virulent NIA-3 strain of ADV 12 weeks after the first vaccination. Apart from mortality, average periods of growth arrest, fever and virus shedding after challenge were used as parameters to evaluate vaccine efficacy. Two inactivated and 4 attenuated vaccines were tested. Two attenuated vaccine viruses were excreted after vaccination. Despite maximal standardization, a considerable variation still existed between the experiments in mortality and growth arrest periods of control pigs after challenge. However, the controls were always more severely affected than the vaccinated pigs. All vaccines except one were effective in preventing death after challenge, but none conferred complete protection. Most vaccinated pigs still lost weight, developed fever and shed virus after challenge. Revaccination after 3 or 4 weeks had little effect, particularly with the attenuated vaccines. The results of the present study indicate that 2 of the attenuated vaccines conferred the best protection, 1 attenuated vaccine appeared to be as effective as the 2 inactivated ones, and the 4th attenuated vaccine was least effective.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996210     DOI: 10.1080/01652176.1985.9693982

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  11 in total

1.  Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells.

Authors:  C C Marchioli; R J Yancey; E A Petrovskis; J G Timmins; L E Post
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Comparative evaluation of an enzyme-linked immunosorbent assay (ELISA) to detect antibodies directed against glycoprotein I of pseudorabies virus and a conventional ELISA and neutralization tests.

Authors:  J T van Oirschot
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

Review 3.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

4.  Efficacy of a killed gpX deleted pseudorabies virus vaccine.

Authors:  D R Cook; H T Hill; D R Kinker
Journal:  Can J Vet Res       Date:  1990-10       Impact factor: 1.310

5.  Bartha-K61 vaccine protects nursery pigs against challenge with novel european and asian strains of suid herpesvirus 1.

Authors:  Konstantinos V Papageorgiou; Margarita Michailidou; Ioannis Grivas; Evanthia Petridou; Efthymia Stamelou; Konstantinos Efraimidis; Lei Chen; Trevor W Drew; Spyridon K Kritas
Journal:  Vet Res       Date:  2022-06-22       Impact factor: 3.829

6.  Virus reactivation in pigs latently infected with a thymidine kinase negative vaccine strain of pseudorabies virus.

Authors:  W L Mengeling
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera.

Authors:  M van Zijl; G Wensvoort; E de Kluyver; M Hulst; H van der Gulden; A Gielkens; A Berns; R Moormann
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted.

Authors:  H E Farrell; C S McLean; C Harley; S Efstathiou; S Inglis; A C Minson
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Assessment of an Aujeszky's Disease Control Strategy in a Highly Prevalent Pig Farm Based on Systematic Vaccination With an Inactivated gE-Negative Marker Vaccine.

Authors:  María N Aznar; Fernando A Bessone; Rodrigo Segurado; Sergio J Duffy
Journal:  Front Vet Sci       Date:  2022-04-22

10.  A Solution with Ginseng Saponins and Selenium as Vaccine Diluent to Increase Th1/Th2 Immune Responses in Mice.

Authors:  Yong Wang; Xuemei Cui; Lijia Yuan; Babar Maqbool; Wei Xu; Shanshan He; Ran Guan; Songhua Hu
Journal:  J Immunol Res       Date:  2020-02-21       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.